Colorectal Cancers: From Present Problems to Future Solutions

The scientific community has made significant progress in our molecular understanding of sporadic and hereditary colorectal carcinogenesis and progression. Thie pertains to, e.g., the discovery of (mutated) oncogenes and tumor suppressor genes, microsatellite instabilities, modifications in DNA repa...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (238 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04626nam-a2201069z--4500
001 993553546904498
005 20231214132927.0
006 m o d
007 cr|mn|---annan
008 202208s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5600000000483111 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/91155 
035 |a (EXLCZ)995600000000483111 
041 0 |a eng 
100 1 |a Allgayer, Heike  |4 edt 
245 1 0 |a Colorectal Cancers: From Present Problems to Future Solutions 
246 |a Colorectal Cancers 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (238 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a The scientific community has made significant progress in our molecular understanding of sporadic and hereditary colorectal carcinogenesis and progression. Thie pertains to, e.g., the discovery of (mutated) oncogenes and tumor suppressor genes, microsatellite instabilities, modifications in DNA repair, cellular aging, signaling cascades, genomic, epigenetic, transcriptional, translational, and protein modifications, as well as microbiotic factors and further parameters. Progression and metastasis have been more intensively studied, especially during recent years, leading to an intensified knowledge on molecular protagonists and microenvironmental interactions contributing to invasion, dissemination, and metastasis; still, more concerted efforts need to be made to better understand issues such as metastasis to different sites or the metastatic heterogeneity of single cells. Nevertheless, based on actual discoveries, personalized medicine, together with highly interdisciplinary therapeutic strategies combining advanced levels of surgical techniques, oncology, and radiation in neoadjuvant, adjuvant, or palliative settings, has started to improve the clinical prognosis of individual patients with colorectal cancer. The present Special Issue features articles of excellent international experts with the latest data in the fields mentioned. With this Special Issue, we aim to deepen discussions amongst colleagues in all kinds of disciplines working on this disease and to intensify interdisciplinary collaborations aimed at an ultimate understanding of strategies to defeat and prevent, colorectal cancer, and its progression. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Oncology  |2 bicssc 
653 |a Phage 
653 |a bacteriophages 
653 |a diet 
653 |a infection 
653 |a colorectal 
653 |a cancer 
653 |a nutrition 
653 |a circulating tumor cells 
653 |a colorectal cancer 
653 |a EPISPOT assay 
653 |a CellSearch® system 
653 |a predictive value 
653 |a chromatin density 
653 |a nanoscale 
653 |a tumour cell heterogeneity 
653 |a microRNAs 
653 |a metastasis 
653 |a super-resolution microscopy 
653 |a early onset 
653 |a cohort 
653 |a epidemiology 
653 |a liquid biopsy 
653 |a biomarker 
653 |a indirect carcinogenesis 
653 |a bovine meat and milk factors (BMMF) 
653 |a chronic zoonosis 
653 |a multiplex 
653 |a tumor immunology 
653 |a immune landscape 
653 |a spontaneous feline intestinal tumors 
653 |a comparative oncology 
653 |a tumor budding 
653 |a CTNNB1 
653 |a genome-wide methylation array 
653 |a methylation 
653 |a miRNA 
653 |a colon cancer 
653 |a personalized treatment 
653 |a drug combinations 
653 |a Matrix Metalloproteinases (MMPs) 
653 |a polyp 
653 |a TIMPs 
653 |a MMP polymorphisms 
653 |a MMP targeting 
653 |a S100A4 
653 |a DKK1 
653 |a Wnt signaling 
653 |a patient survival 
653 |a gender 
653 |a rectal cancer 
653 |a radiochemotherapy 
653 |a radiosensitivity 
653 |a DNA double-strand breaks 
653 |a deposited energy 
653 |a quality of life 
653 |a blood values 
653 |a (molecular) carcinogenesis 
653 |a cancer progression 
653 |a (single) cancer cell heterogeneity 
653 |a models 
653 |a infectious agents 
653 |a (targeted) therapy 
653 |a personalized medicine 
776 |z 3-0365-4727-4 
776 |z 3-0365-4728-2 
700 1 |a Allgayer, Heike  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:36:03 Europe/Vienna  |f system  |c marc21  |a 2022-08-13 21:17:26 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5339473880004498&Force_direct=true  |Z 5339473880004498  |b Available  |8 5339473880004498